Selectivity in the Inhibition of HIV and FIV Protease: Inhibitory and Mechanistic Studies of Pyrrolidine-Containing .alpha.-Keto Amide and Hydroxyethylamine Core Structures

This paper describes the development of new pyrrolidine-containing alpha-keto amide and hydroxyethylamine core structures as mechanism based inhibitors of the HIV and FIV proteases. It was found that the alpha-keto amide core structure 2 is approximately 300-fold better than the corresponding hydrox...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American Chemical Society Vol. 117; no. 48; pp. 11867 - 11878
Main Authors Slee, Deborah H, Laslo, Karen L, Elder, John H, Ollmann, Ian R, Gustchina, Alla, Kervinen, Jukka, Zdanov, Alexander, Wlodawer, Alexander, Wong, Chi-Huey
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 01.12.1995
Amer Chemical Soc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This paper describes the development of new pyrrolidine-containing alpha-keto amide and hydroxyethylamine core structures as mechanism based inhibitors of the HIV and FIV proteases. It was found that the alpha-keto amide core structure 2 is approximately 300-fold better than the corresponding hydroxyethylamine isosteric structure and 1300-fold better than the corresponding phosphinic acid derivative as an inhibitor of the HIV protease. The alpha-keto amide is however not hydrated until it is bound to the HIV protease as indicated by the NMR study and the X-ray structural analysis. Further analysis of the inhibition activities of hydroxyethylamine isosteres containing modified pyrrolidine derivatives revealed that a cis-methoxy group at C-4 of the pyrrolidine would improve the binding 5-and 25-fold for the trans-isomer. When this strategy was applied to the alpha-keto amide isostere, a cis-benzyl ether at C-4 was found to enhance binding 3-fold. Of the core structures prepared as inhibitors of the HIV protease, none show significant inhibitory activity against the mechanistically identical FIV protease, and additional complementary groups are needed to improve inhibition.
Bibliography:istex:843F3E97C9FE93BED24C5FBB01946BCD6922EF53
ark:/67375/TPS-VP43D7B3-K
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0002-7863
1520-5126
DOI:10.1021/ja00153a008